摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(±)-perhydrogephyrotoxin | 63983-59-5

中文名称
——
中文别名
——
英文名称
(±)-perhydrogephyrotoxin
英文别名
(+/-)-perhydrogephyrotoxin;2-[(1S,3aS,5aS,6R,9aR)-6-pentyl-1,2,3,3a,4,5,5a,6,7,8,9,9a-dodecahydropyrrolo[1,2-a]quinolin-1-yl]ethanol
(±)-perhydrogephyrotoxin化学式
CAS
63983-59-5;74163-97-6;74163-98-7
化学式
C19H35NO
mdl
——
分子量
293.493
InChiKey
HTKBYBVWXZGWBV-ZSXDVEMLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.4
  • 重原子数:
    21
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    23.5
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    (2R,4aS,5R,8aR)-2-((E)-5,5-Dimethoxy-pent-3-enyl)-5-pentyl-octahydro-quinoline-1-carboxylic acid 2,2,2-trichloro-ethyl ester 在 lead 、 ammonium acetate 、 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 生成 (±)-perhydrogephyrotoxin
    参考文献:
    名称:
    A short total synthesis of (.+-.)-perhydrogephyrotoxin
    摘要:
    DOI:
    10.1021/jo00326a060
点击查看最新优质反应信息

文献信息

  • Total Syntheses of (±)-Gephyrotoxin and (±)-Perhydrogephyrotoxin
    作者:Kenji Shirokane、Yuya Tanaka、Makoto Yoritate、Nobuaki Takayama、Takaaki Sato、Noritaka Chida
    DOI:10.1246/bcsj.20140398
    日期:2015.4.15
    This article describes the full details of our total syntheses of gephyrotoxin and perhydrogephyrotoxin. Our central strategy toward the total synthesis is based on the use of an N-methoxy group as...
    这篇文章描述了我们对 gephyrotoxin 和 perhydrogephyrotoxin 进行全合成的全部细节。我们全合成的核心策略是基于使用 N-甲氧基作为...
  • A novel synthetic route to (±)-perhydrogephyrotoxin
    作者:Toshiro Ibuka、G.-Namg Chu、Fumio Yoneda
    DOI:10.1039/c39840000597
    日期:——
    Total synthesis of (±)-perhydrogephyrotoxin (3) starting from 1,3-bis (trimethylsiloxy) buta-1,3-diene is presented; an efficient new decarboxylative reduction of γ-carbamoyloxy-α,β-enoate (14) by lithium dibutylcuprate is also presented.
    提出了从1,3-双(三甲基甲硅烷氧基)丁1,3-二烯开始的(±)-过氢地理植物毒素(3)的全合成。还提出了一种有效的新的二丁基铜酸锂脱羧还原γ-氨基甲酰氧基-α,β-烯酸酯(14)的方法。
  • A new stereoselective synthesis of (.+-.)-perhydrogephyrotoxin.
    作者:TOSHIRO IBUKA、GIL NAMG CHU
    DOI:10.1248/cpb.34.2380
    日期:——
    A stereoselective synthesis of (±)-perhydorgephyrotoxin (3) starting from 1, 3-bis(trimethyl-siloxy)-1, 3-butadiene and ethyl trans-2-octenoate is described. A crucial step is reductive decarboxylation of the γ-carbamoyloxy-α, β-enoate (6) with lithium dibutylcuprate to yield the β, γ-enoate (40).
    本研究描述了以 1,3-双(三甲基硅氧基)-1,3-丁二烯和反式-2-辛烯酸乙酯为起始原料,立体选择性合成 (±)-perhydorgephyrotoxin (3)。其中一个关键步骤是用苝酸二丁酯锂对γ-氨基甲酰氧基-α,β-烯酸酯(6)进行还原脱羧反应,生成β,γ-烯酸酯(40)。
  • Total synthesis of (.+-.)-gephyrotoxin
    作者:Roger Fujimoto、Yoshito Kishi、John F. Blount
    DOI:10.1021/ja00543a067
    日期:1980.11
    numerous synthetic studies. Total syntheses have been reported by Kishi, Hart, Overman, as well as Sato and Chida, and a number of formal syntheses have been described. Smith and co-workers now report an elegant and concise synthesis of gephyrotoxin that relies on an intramolecular enamine/Michael cascade to access the tricyclic scaffold of the natural product. Comment: The synthesis commenced with L-pyroglutaminol
    意义:Gephyrotoxin 是一种相对无毒的 dendrobatid 生物碱,具有不寻常的神经学特征。它的特性和复杂的结构使其成为众多合成研究的主题。Kishi、Hart、Overman 以及 Sato 和 Chida 已经报道了全合成,并且已经描述了许多正式的合成。Smith 及其同事现在报告了一种优雅简洁的 gephyrotoxin 合成方法,该合成方法依赖于分子内烯胺/迈克尔级联反应来获取天然产物的三环支架。评论:合成从 L-焦谷氨酰胺 (A) 开始,通过五个简单的步骤将其转化为关键中间体 F。通过用 TFA 处理实现 F 的脱保护,并在氯仿中加热至 40 °C 导致形成亚胺盐 H,其依次进行羟基定向还原以 79% 的产率得到 I。一些官能团相互转化然后导致 K。与炔烃 L 交叉偶联,然后去保护提供合成 gephyrotoxin。H
  • Stereoselective total synthesis of (.+-.)-perhydrogephyrotoxin. Synthetic applications of directed 2-azonia-[3,3]-sigmatropic rearrangements
    作者:Larry E. Overman、Chikara Fukaya
    DOI:10.1021/ja00524a057
    日期:1980.2
查看更多

同类化合物

桥虫毒素 7-[(1Z)-1,3-丁二烯基]-2-[(2Z)-2-戊烯-4-炔基]-1-氮杂螺[5.5]十一烷-8-醇 (2S,6R,7S,8S)-7-[(E)-丁-1-烯-3-炔基]-2-[(E)-戊-2-烯-4-炔基]-1-氮杂螺[5.5]十一烷-8-醇 (2R,6R,7alpha,8beta)-7-[(Z)-1-丁烯-3-炔基]-2-(4-戊炔基)-1-氮杂螺[5.5]十一烷-8-醇 12-(4-chlorobut-1-en-3-ynyl)-5-(5-chloropent-2-en-4-ynyl)-7-oxa-6-azatricyclo[6.3.1.01,6]dodecane 6,8.0]undecane">(2S,6R,7S,8S)-(2'Z, 1"Z)-2-(penta-2',4'-dienyl)-7-(4''-triisopropylsilyl-but-1''-en-3''-yn-1''-yl)-1-aza-12-oxatricyclo[5.4.16,8.0]undecane (-)-histrionicotoxin 285E 6,8.0]undecane">(2S,6R,7S,8S)-2-(prop-2'-enyl)-7-(4"-triisopropylsilyl-but-1"-en-3"-yn-1"-yl)-1-aza-12-oxatricyclo[5.4.16,8.0]undecane (-)-histrionicotoxin 259A 2,7-epi-(+/-)-Perhydrohistrionicotoxin isodihydrohistrionicotoxin allodihydrohistrionicotoxin 6,8.0]undecane">(2S,6R,7S,8S)-(1"Z)-2-(5'-trimethylsilylpent-4'-ynl)-7-(4''-trimethylsilyl-but-1''-en-3''-yn-1''-yl)-1-aza-12-oxatricyclo[5.4.16,8.0]undecane Octahydrohistrionicotoxin (±)-perhydrogephyrotoxin (±)-gephyrotoxin dl-dihydrogephyrotoxin 2-[(1R,3aR,5aR,6R,9aS)-6-[(Z)-pent-2-en-4-ynyl]-1,2,3,3a,4,5,5a,6,7,8,9,9a-dodecahydropyrrolo[1,2-a]quinolin-1-yl]ethyl 4-bromobenzoate (2S,6R,7S,8S)-(1'Z)-2-cyanomethyl-7-(but-1'-en-3'-yn-1'-yl)-1-aza-12-oxatricyclo [5.4.16,8.0]undecane 2-[(1S,3aS,5aS,6S,9aR)-((E)-6-Pent-2-en-4-ynyl)-dodecahydro-pyrrolo[1,2-a]quinolin-1-yl]-ethanol benzyl (1'S,3'R,4R,5R,6'S,8'S)-5'-oxo-3'-pentyl-4,5-diphenyl-7'-propylspiro[1,3-dioxolane-2,9'-2-azatricyclo[6.4.0.01,6]dodecane]-2'-carboxylate benzyl (2R,3R,6S,7S,9R)-6-butyl-11-oxo-9-pentyl-2,3-diphenyl-1,4-dioxa-8-azadispiro[4.1.57.35]pentadecane-8-carboxylate 2-(6-[(2Z)-2,4-Pentadienyl]dodecahydropyrrolo[1,2-a]quinolin-1-yl)ethanol Histrionicotoxin 285b delta-17-trans-Histrionicotoxin 283a' 2-((1S,3aS,5aS,6S,9aR)-6-((Z)-Pent-2-en-4-yn-1-yl)dodecahydropyrrolo[1,2-a]quinolin-1-yl)ethanol (2R,6R,7S,8S)-7-((Z)-But-1-en-1-yl)-2-pentyl-1-azaspiro[5.5]undecan-8-ol Histionicotoxin 285c 2-(6-[(2E)-2-Penten-4-ynyl]dodecahydropyrrolo[1,2-a]quinolin-1-yl)ethyl 4-bromobenzoate Dihydrohistrionicotoxin 285e Isotetrahydrohistrionicotoxin 287a (2S,6R,7S,8S)-2-Allyl-7-((Z)-but-1-en-3-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol 11-[(1E)-buta-1,3-dienyl]-2-prop-2-enyl-1-azaspiro[5.5]undecan-10-ol Tetrahydrohistrionicotoxin 287b (2R,6R,7S,8S)-7-(But-3-en-1-yl)-2-(pent-4-en-1-yl)-1-azaspiro[5.5]undecan-8-yl acetate (2S,6R,7S,8S)-7-((Z)-But-1-en-3-yn-1-yl)-2-((Z)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol (2S,6R,7S,8S)-2-Allyl-7-((Z)-buta-1,3-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol (2S,6R,7S,8S)-7-((Z)-But-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol (2S,6R,10S,11S)-11-but-1-en-3-ynyl-2-prop-2-enyl-1-azaspiro[5.5]undecan-10-ol 2-(6-pent-2-en-4-ynyl-1,2,3,3a,4,5,5a,6,7,8,9,9a-dodecahydropyrrolo[1,2-a]quinolin-1-yl)ethyl 4-bromobenzoate (2S,6R,7S,8S)-(1'Z)-2-(cyanomethyl)-7-(4'-triisopropylsilyl-but-1'-en-3'-yn-1'-yl)-1-aza-12-oxatricyclo[5.4.16,8.0]undecane Allodihydrobistrionicotoxin 11-Buta-1,3-dienyl-2-pent-4-ynyl-1-azaspiro[5.5]undecan-10-ol 2-(6-Penta-2,4-dienyl-1,2,3,3a,4,5,5a,6,7,8,9,9a-dodecahydropyrrolo[1,2-a]quinolin-1-yl)ethanol 11-But-1-en-3-ynyl-2-prop-2-enyl-1-azaspiro[5.5]undecan-10-ol (+/-)-Octahydrohistrionicotoxin 11-Buta-1,3-dienyl-2-prop-2-enyl-1-azaspiro[5.5]undecan-10-ol 7-but-1-en-3-ynyl-2-pent-2-en-4-ynyl-1-aza-spiro[5.5]undecan-8-ol 2-(6-Pent-2-en-4-ynyl-1,2,3,3a,4,5,5a,6,7,8,9,9a-dodecahydropyrrolo[1,2-a]quinolin-1-yl)ethanol